Search

everythinglearnresearchcommunity

for

Search:↓

TIP39 and PTH2R help control calcium levels and skin cell development.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Nelfb is crucial for forming skin fat tissue by regulating genes needed for fat cell development.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Sphingosine 1-phosphate affects inflammation and gene expression in different aorta cells.

Ku80 is a key receptor for Thymosin β4, affecting cell migration and wound healing.

Higher CRBP1 levels are linked to more severe alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.